GALE : Analysis & Opinions

  1. Galena Declares 1-for-20 Reverse Split (GALE)

    November 14, 2016
    Galena’s 1-for-20 reverse stock split goes ex-today, which will bump the share price by a factor of 20.
  2. Galena Biopharma 3Q Loss $6.9M or 3c/Share (GALE)

    November 11, 2016
    Galena posted a third-quarter loss of $6.9 million, but won an exclusive patent in Japan.
  3. Galena Wins Exclusive Japanese Patent (GALE)

    September 19, 2016
    The grant of a long-term exclusive patent in Japan will allow Galena to benefit in the long run from MPN disease treatment.
  4. Why 78% Is Galena Biopharma's Magic Number

    June 29, 2015
    Have you ever had a feeling of deja vu? You know, that uncanny feeling that you're experiencing something you've been through ...
  5. What's Behind Galena's 58% Rise in 2 Weeks?

    June 10, 2015
    Within the biotechnology sector there pretty much hasn't been a hotter company over the last two weeks than Galena Biopharma ...
  6. 5 Things Galena Biopharma Wants You to Know

    May 28, 2015
    In early May, Galena Biopharma (NASDAQ: GALE), a predominantly clinical-stage biopharmaceutical company focused on developing ...
  7. Galena Biopharma Earnings: NeuVax or Bust

    May 8, 2015
    Predominantly clinical-stage biopharmaceutical companies often get a pass come earnings time, but when remaining cash on ...
  8. 4 Ways Galena Biopharma Could Disappoint Investors

    March 31, 2015
    When it comes to investing in small-cap biotech stocks, the chips are firmly stacked in favor of the pessimists. Although ...